Search In this Thesis
   Search In this Thesis  
العنوان
Formulation And Evaluation Of Novel Drug Delivery System For Doxylamine Succinate And Pyridoxine Hydrochloride /
المؤلف
Hassan, Abdel-Rahman Abdel-Moneim Sadek.
هيئة الاعداد
باحث / عبدالرحمن عبدالمنعم صادق حسن
abdo.41@yahoo.com
مشرف / هبه فاروق سالم
مشرف / عادل احمد علي
مشرف / هبة محمود عبود
الموضوع
Succinates. Pyridoxine.
تاريخ النشر
2022.
عدد الصفحات
300 P. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الصيدلة
الناشر
تاريخ الإجازة
29/7/2022
مكان الإجازة
جامعة بني سويف - كلية الصيدلة - صيدلانيات والصيدلة الصناعية
الفهرس
Only 14 pages are availabe for public view

from 289

from 289

Abstract

The Present Work Is Concerned With Tailoring And Appraisal Of A Novel Nano-Cargo; Bilosomes (BLS) Dual Laded With Doxylamine Succinate (DAS) And Pyridoxine Hydrochloride (PDH), The First Treatment Option Against Gestational Nausea And Vomiting, For Intranasal Delivery. This Bifunctional Horizon Could Surmount Constraints Of Orally-Commercialized Platforms Both In Dosage Regimen And Pharmacokinetic Profile. For Accomplishing This Purpose, DAS/PDH-BLS Were Elaborated Embedding Phospholipid, Sodium Cholate And Cholesterol Applying Thin-Film Hydration Method Based On Box-Behnken Design. Utilizing Design-Expert® Software, The Effect Of Formulation Variables On BLS Physicochemical Features Alongside The Optimal Formulation selection Were Investigated. Then, The Optimum DAS/PDH-BLS Formulation Was Incorporated Into A Thermally-Triggered In Situ Gelling Base. The In Vivo Pharmacokinetic Studies Were Scrutinized In Rats For Intranasal DAS/PDH-BLS In Situ Gel Compared With Analogous Intranasal Free In Situ Gel And Oral Solution. The Optimized BLS Disclosed Particle Size Of 243.23 Nm, Ζ Potential Of -31.33 Mv, Entrapment Efficiency Of 59.18 And 41.63%, Accumulative % Release Within 8 H Of 63.30 And 85.52% And Accumulative Permeated Amount Over 24 H Of 347.92 And 195.4 µg/Cm2 For DAS/PDH, Respectively. Following Intranasal Administration Of The Inspected BLS In Situ Gel, Pharmacokinetic Studies Revealed A 1.64- And 2.3-Fold Increment In The Relative Bioavailability Of DAS And A 1.7- And 3.73-Fold Increase For PDH Compared To The Intranasal Free In Situ Gel And Oral Solution, Respectively Besides Significantly Extended Mean Residence Times For Both Drugs. Thus, The Intranasally Harnessed DAS/PDH-BLS Could Be Deemed As A Competent Hybrid Nanoplatform With Auspicious Pharmacokinetics And Tolerability Traits.
Keywords: Doxylamine Succinate; Pyridoxine Hydrochloride; Emesis Gravidarum; Intranasal Delivery; Bilosomes; Pharmacokinetics.